Blog
Gold Seal GuideStar
NETRF given the highest ranking for financial responsibility and transparency by leading nonprofit rating program, GoldStar.
April 16, 2019
No Comments
Category: Donors
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
The Power of Persistence
A few weeks ago, I heard Dr. James Allison, a scientist at MD Anderson Cancer Center and winner of the 2018 Nobel Prize for Physiology
April 11, 2019
No Comments
Blog
National Doctor’s Day
NETRF invites your participation in a special, upcoming holiday. National Doctor’s Day will be celebrated on Saturday, March 30th and it is a great opportunity
March 21, 2019
No Comments
Donors
Celebrating Progress in Treating Neuroendocrine Tumors
When I look back on 2018, I see tremendous growth and progress in the field of NETs and in NETRF. We are proud of our
March 7, 2019
No Comments
Donors
Celebrating Progress in Treating Neuroendocrine Tumors
2018 was off to a game-changing start when the FDA approved Lutetium 177 dotatate for gastrointestinal and pancreatic NETs—the first PRRT radiopharmaceutical approved in the United States.
February 1, 2019
No Comments
Blog
CarGurus Makes Grant to NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) gratefully received a $35,000 donation for NET research from the CarGurus Charitable Giving Fund. NETRF was nominated by a
October 16, 2018
No Comments
Blog
Spark Hope: A $10 Million Campaign for NET Research
NETRF has launched a $10 million fundraising campaign, the largest of its kind in our history. Every gift we receive will be MATCHED, doubling our
October 11, 2018
No Comments
Blog
Leaving Neuroendocrine Cancer Behind
NET Survivor Finds Hope and Inspiration That’s it—my number is up, Dave McCoy thought when he learned he had neuroendocrine cancer in 2008. A cancer, he
October 11, 2018
5 Comments
Blog
NET Research Foundation Seeks to Raise $10 Million with Spark Hope Campaign
Research Aimed at Expanding Effective Treatment Options for Neuroendocrine Tumors The Neuroendocrine Tumor Research Foundation, Boston, MA, the leading funder of neuroendocrine tumor (NET) research,
September 27, 2018
No Comments
Blog
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 11, 2018
1 Comment